FindTrial
Sign In

ASSESSMENT OF VITAMIN D LEVELS IN CHILDREN WITH NEPHROTIC SYNDROME

ASSESSMENT OF VITAMIN D LEVELS IN NEPHROTIC SYNDROME

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/11/029381
Enrollment
30
Registered
2020-11-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N040- Nephrotic syndrome with minor glomerular abnormality

Interventions

Control Intervention1: nil: nil

Sponsors

Kasturba Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children aged 1-18yrs and presenting as first episode of Nephrotic Syndrome or in Active disease and not currently on steroid therapy.

Exclusion criteria

Exclusion criteria: Children who have taken Vitamin D supplementation in the past 3 months abnormal GFR On antiepileptic Remission of nephrotic syndrome New cases of nephrotic syndrome who have received steroid therapy. Steroid resistant Nephrotic syndrome

Design outcomes

Primary

MeasureTime frame
Vitamin D levels as a risk factor for Nephrotic syndrome Timepoint: at the beginning of the study i.e. baseline—

Secondary

MeasureTime frame
The number of relapses with respect to their Vitamin D levels Timepoint: July 2021—

Countries

India

Contacts

Public ContactSaumya Srivastava

Kasturba Medical College

saumya.srivastava0767@gmail.com7259604868

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026